Skip to main content

Table 2 EORTC-C30 and -BN20 domain and single item's scores before and during VMAT

From: Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-life

QoL Pre-VMAT score ± SD Score during VMAT ± SD p value
C30    
Global Health Status 62.5 ± 26.4 62.0 ± 21.4 0.92
Physical functioning 78.9 ± 22.9 65.1 ± 31.2 0.05
Emotional functioning 74.8 ± 20.1 74.3 ± 27.0 0.86
Role functioning 75.0 ± 21.6 55.5 ± 37.1 0.02
BN20 domains/items    
Domains    
Future uncertainty 30.8 ± 20.9 18.8 ± 23.5 0.07
Visual disorder 13.6 ± 20.7 13.3 ± 17.4 0.92
Motor dysfunction 22.5 ± 24.1 22.2 ± 26.9 0.64
Communication deficit 19.7 ± 28.1 13.6 ± 16.8 0.13
Single items    
Headache 37.0 ± 41.0 18.5 ± 23.5 < 0.05
Hair loss 14.8 ± 30.7 3.7 ± 15.7 0.11
Weakness of legs 24.1 ± 29.8 25.9 ± 31.4 0.58
Bladder control 16.7 ± 30.8 14.8 ± 28.5 0.79
  1. Abbreviations: QoL: Quality of life; SD, standard deviation.